Gland Pharma Limited
Held by 174 mutual fund schemes, ₹16,160Cr between them.
The largest single position is HDFC Mid Cap Fund (HDFC), which holds 1.9% of its portfolio in Gland Pharma Limited — ₹1,970Cr, or 12.2% of all the mutual fund money in this stock.
The five largest holders account for 37% of it, across 174 schemes in total.
14 of the 60 largest holdings sit in sectoral/ thematic funds, the most of any category here.
Funds holding Gland Pharma Limited
174Largest rupee position first, top 60 shown. One row per scheme — a fund’s Direct and Regular plans hold the same portfolio, so the Direct plan stands for both.
| Fund | Category | Weight | Position | Fund size |
|---|---|---|---|---|
| HDFC Mid Cap Fund | Mid Cap Fund | 1.87% | ₹1,970Cr | ₹1,05,346Cr |
| Kotak Mid Cap Fund | Mid Cap Fund | 2.24% | ₹1,551Cr | ₹69,235Cr |
| SBI Large & Midcap Fund | Large & Mid Cap Fund | 2.47% | ₹1,035Cr | ₹41,910Cr |
| Nippon India Growth Mid Cap Fund | Mid Cap Fund | 1.77% | ₹905.22Cr | ₹51,142Cr |
| Nippon India Small Cap Fund | Small Cap Fund | 0.74% | ₹598.22Cr | ₹80,841Cr |
| HDFC Large & Mid Cap Fund | Large & Mid Cap Fund | 1.54% | ₹459.91Cr | ₹29,864Cr |
| DSP Small Cap Fund | Small Cap Fund | 2.01% | ₹419.22Cr | ₹20,857Cr |
| Axis Small Cap Fund | Small Cap Fund | 1.36% | ₹417.59Cr | ₹30,705Cr |
| ICICI Prudential India Opportunities Fund | Sectoral/ Thematic | 1.07% | ₹406.19Cr | ₹37,976Cr |
| Mirae Asset Large & Midcap Fund | Large & Mid Cap Fund | 0.90% | ₹403.48Cr | ₹44,976Cr |
| Nippon India Multi Cap Fund | Multi Cap Fund | 0.70% | ₹388.96Cr | ₹55,566Cr |
| SBI Contra Fund | Contra Fund | 0.78% | ₹370.23Cr | ₹47,465Cr |
| Axis Midcap Fund | Mid Cap Fund | 0.97% | ₹335.39Cr | ₹34,576Cr |
| Nippon India ELSS Tax Saver Fund | ELSS | 2.22% | ₹327.22Cr | ₹14,739Cr |
| Mirae Asset Midcap Fund | Mid Cap Fund | 1.54% | ₹312.84Cr | ₹20,305Cr |
| Canara Robeco Small Cap Fund | Small Cap Fund | 2.11% | ₹302.92Cr | ₹14,356Cr |
| UTI - Flexi Cap Fund. | Flexi Cap Fund | 1.21% | ₹286.34Cr | ₹23,664Cr |
| Sundaram Mid Cap Fund | Mid Cap Fund | 1.81% | ₹261.68Cr | ₹14,485Cr |
| Nippon India Pharma Fund | Sectoral/ Thematic | 2.73% | ₹253.12Cr | ₹9,272Cr |
| DSP Healthcare Fund | Sectoral/ Thematic | 6.61% | ₹245.95Cr | ₹3,721Cr |
| DSP Midcap Fund | Mid Cap Fund | 1.16% | ₹237.92Cr | ₹20,510Cr |
| Mirae Asset Large Cap Fund | Large Cap Fund | 0.52% | ₹197.35Cr | ₹38,047Cr |
| Axis Large & Mid Cap Fund | Large & Mid Cap Fund | 1.08% | ₹182.31Cr | ₹16,881Cr |
| HDFC Multi Cap Fund | Multi Cap Fund | 0.84% | ₹171.69Cr | ₹20,439Cr |
| HDFC Manufacturing Fund | Sectoral/ Thematic | 1.62% | ₹171.06Cr | ₹10,559Cr |
| SBI Healthcare Opportunities Fund | Sectoral/ Thematic | 3.06% | ₹170.30Cr | ₹5,565Cr |
| Axis ELSS- Tax Saver Fund | ELSS | 0.51% | ₹163.93Cr | ₹32,144Cr |
| UTI - Mid Cap Fund | Mid Cap Fund | 1.31% | ₹162.72Cr | ₹12,421Cr |
| Axis Multicap Fund | Multi Cap Fund | 1.34% | ₹153.17Cr | ₹11,430Cr |
| Aditya Birla Sun Life MNC Fund | Sectoral/ Thematic | 3.82% | ₹124.33Cr | ₹3,252Cr |
| UTI - MNC Fund | Sectoral/ Thematic | 4.52% | ₹124.06Cr | ₹2,745Cr |
| Canara Robeco Aggressive Hybrid Fund | Aggressive Hybrid Fund | 1.04% | ₹117.24Cr | ₹11,273Cr |
| Kotak Aggressive Hybrid Fund | Aggressive Hybrid Fund | 1.23% | ₹113.31Cr | ₹9,212Cr |
| Mirae Asset Multicap Fund | Multi Cap Fund | 1.99% | ₹109.73Cr | ₹5,502Cr |
| ICICI Prudential Healthcare Fund | Sectoral/ Thematic | 1.57% | ₹106.92Cr | ₹6,830Cr |
| Aditya Birla Sun Life Small Cap Fund | Small Cap Fund | 1.70% | ₹102.71Cr | ₹6,030Cr |
| Mirae Asset Small Cap Fund | Small Cap Fund | 1.85% | ₹100.89Cr | ₹5,463Cr |
| HSBC Large & Mid Cap Fund | Large & Mid Cap Fund | 1.76% | ₹99.75Cr | ₹5,668Cr |
| SBI Conservative Hybrid Fund | Conservative Hybrid Fund | 0.96% | ₹97.87Cr | ₹10,195Cr |
| Mirae Asset Healthcare Fund | Sectoral/ Thematic | 2.82% | ₹97.34Cr | ₹3,458Cr |
| Aditya Birla Sun Life Value Fund | Value Fund | 1.35% | ₹91.75Cr | ₹6,807Cr |
| SBI MNC Fund | Sectoral/ Thematic | 1.38% | ₹89.76Cr | ₹6,504Cr |
| Axis India Manufacturing Fund | Sectoral/ Thematic | 1.56% | ₹86.87Cr | ₹5,569Cr |
| Mirae Asset ELSS Tax Saver Fund | ELSS | 0.30% | ₹79.61Cr | ₹26,128Cr |
| ICICI Prudential Manufacturing Fund | Sectoral/ Thematic | 1.12% | ₹79.30Cr | ₹7,085Cr |
| Sundaram Aggressive Hybrid Fund | Aggressive Hybrid Fund | 0.82% | ₹75.30Cr | ₹9,137Cr |
| DSP Multi Cap Fund | Multi Cap Fund | 2.47% | ₹73.45Cr | ₹2,974Cr |
| Aditya Birla Sun Life Aggressive Hybrid Fund | Aggressive Hybrid Fund | 1.01% | ₹71.99Cr | ₹7,143Cr |
| TRUSTMF Small Cap Fund | Small Cap Fund | 2.00% | ₹64.09Cr | ₹3,204Cr |
| WhiteOak Capital Mid Cap Fund | Mid Cap Fund | 0.89% | ₹63.15Cr | ₹7,096Cr |
| Sundaram Multi Cap Fund | Multi Cap Fund | 1.90% | ₹56.97Cr | ₹3,003Cr |
| HDFC Retirement Fund - Equity | Retirement Fund | 0.81% | ₹56.08Cr | ₹6,923Cr |
| UTI - Healthcare Fund | Sectoral/ Thematic | 3.89% | ₹54.43Cr | ₹1,399Cr |
| UTI Small Cap Fund | Small Cap Fund | 0.93% | ₹49.74Cr | ₹5,348Cr |
| ICICI Prudential Active Momentum Fund | Sectoral/ Thematic | 2.27% | ₹47.91Cr | ₹2,110Cr |
| Aditya Birla Sun Life Large & Mid Cap Fund | Large & Mid Cap Fund | 0.81% | ₹47.26Cr | ₹5,842Cr |
| Nippon India Nifty Pharma ETF | Other ETFs | 2.44% | ₹41.48Cr | ₹1,700Cr |
| HSBC Multi Asset Allocation Fund | Multi Asset Allocation | 1.29% | ₹40.78Cr | ₹3,161Cr |
| Nippon India Nifty Smallcap 250 Index Fund | Index Funds | 1.17% | ₹40.52Cr | ₹3,463Cr |
| Canara Robeco Multi Cap Fund | Multi Cap Fund | 0.66% | ₹38.15Cr | ₹5,780Cr |
Weights come from each fund’s most recent disclosed portfolio, which SEBI requires monthly — positions can have changed since. “Position” is the weight applied to the scheme’s AUM, available for 167 of the 174 holders. Nothing here is advice, and a stock being widely held is not an argument for owning it.
Funds buying and selling Gland Pharma Limited
In their latest monthly disclosure, 36 funds bought and 18 sold, judged by share count.
Frequently asked questions
Which mutual fund holds the most Gland Pharma Limited?
By rupee value, HDFC Mid Cap Fund from HDFC — ₹1,970Cr, at 1.9% of that scheme's portfolio. Weights come from each fund's most recent disclosed portfolio; SEBI requires monthly disclosure, so a fund that has traded since its last filing may hold more or less than this.
Which fund has the highest weight in Gland Pharma Limited?
DSP Healthcare Fund carries the largest weight at 6.6% of its portfolio. That is a different question from the largest rupee position — a small fund can hold a much bigger share of itself in one stock than a large fund does.
How many mutual funds hold Gland Pharma Limited?
174 schemes, holding ₹16,160Cr between them across the 167 whose AUM is on record. One row per scheme: a fund's Direct and Regular plans hold the same portfolio, so the Direct plan stands for both rather than counting twice.
Does a fund holding Gland Pharma Limited make it a good investment?
No. This page reports what funds disclosed they own, not a view on the stock or on any scheme holding it. A widely held stock is a popular one, which is a fact about other people's positions rather than about future returns. Nothing here is investment advice.